AgomAb Therapeutics NV ( AGMB) has filed to raise $200 million in development capital in an IPO of its American Depositary Shares representing underlying common shares, according to SEC F-1/A ...

By reconstructing a non-natural metabolic route in Escherichia coli, the researchers demonstrated that simple sugars can be ...

AUSTIN, Texas, Jan. 6, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...

The Gatton Academy presented at the Kentucky Junior Academy of Science. Two selected to go on to the American Junior Academy ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 7 includes Pfizer, Philip Morris International, ...

Durham Regional Police said a man is missing and three other men were taken to a hospital in stable condition for smoke ...

The findings show that prolonged targeted therapy in patients with head and neck cancer can heighten tumor alertness, ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...

Microsoft has unveiled Rho-alpha, a next-generation robotics AI model designed to help machines understand the physical world ...

NEW YORK, Dec 31 (Reuters) - Bridgewater Associates' main macro funds delivered a record-breaking performance in 2025, with its flagship Pure Alpha fund generating a 33% jump, buoyed by a robust year ...

University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse ...